MeSH term
Frequency | Condition_Probility | *DNA Methylation | 6 | 0.0 |
Enzyme Precursors/*antagonists & inhibitors/*genetics/metabolism | 2 | 100.0 |
Female | 13 | 0.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Gene Silencing | 2 | 0.0 |
Humans | 179 | 0.0 |
Phenotype | 3 | 0.0 |
Protein-Tyrosine Kinase/*antagonists & inhibitors/*genetics/metabolism | 2 | 100.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 15 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 128 | 0.0 |
Stilbenes/pharmacology | 10 | 30.0 |
Blood Platelets/*metabolism | 9 | 3.0 |
Enzyme Precursors/metabolism | 38 | 27.0 |
Immunoblotting | 8 | 0.0 |
Integrins/metabolism | 3 | 1.0 |
Phosphotyrosine/*chemistry | 2 | 28.0 |
Platelet Activation | 4 | 2.0 |
Precipitin Tests | 13 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 33 | 3.0 |
Research Support, Non-U.S. Gov't | 178 | 0.0 |
Thrombin/*metabolism | 2 | 2.0 |
Tyrosine/metabolism | 35 | 2.0 |
Adult | 8 | 0.0 |
Collagen/*pharmacology | 3 | 11.0 |
Male | 11 | 0.0 |
Phosphorylation | 133 | 1.0 |
Receptors, IgG/metabolism | 7 | 9.0 |
Stress, Mechanical | 2 | 0.0 |
Adolescent | 3 | 0.0 |
Antigens, CD/*metabolism | 6 | 0.0 |
B-Lymphocytes/cytology/*metabolism | 2 | 8.0 |
Cell Division | 4 | 0.0 |
Child | 2 | 0.0 |
Ligands | 9 | 0.0 |
Receptors, IgG/*metabolism | 8 | 13.0 |
*Signal Transduction | 23 | 1.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 5 | 0.0 |
Amino Acid Sequence | 48 | 0.0 |
Animals | 149 | 0.0 |
B-Lymphocytes/*immunology | 8 | 0.0 |
Carrier Proteins/*metabolism | 4 | 0.0 |
Cell Line | 52 | 0.0 |
Enzyme Precursors/deficiency/genetics/*metabolism | 2 | 100.0 |
Phosphoproteins/*metabolism | 8 | 1.0 |
Phosphotyrosine/metabolism | 22 | 5.0 |
Protein-Tyrosine Kinase/deficiency/genetics/*metabolism | 3 | 23.0 |
Receptors, Antigen, T-Cell/chemistry/*metabolism | 2 | 15.0 |
Signal Transduction/*physiology | 9 | 0.0 |
*Tyrosine | 2 | 4.0 |
Aged | 4 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Cell Differentiation | 5 | 0.0 |
Middle Aged | 6 | 0.0 |
*Adaptor Proteins, Signal Transducing | 17 | 1.0 |
Antigens, CD3/metabolism | 4 | 2.0 |
Base Sequence | 21 | 0.0 |
Cloning, Molecular | 11 | 0.0 |
Conserved Sequence | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 4 | 0.0 |
Down-Regulation | 5 | 0.0 |
Jurkat Cells | 13 | 0.0 |
Mice | 70 | 0.0 |
Molecular Sequence Data | 53 | 0.0 |
*Nuclear Proteins | 3 | 0.0 |
Receptors, Antigen, T-Cell/*metabolism | 4 | 2.0 |
Signal Transduction | 58 | 1.0 |
Transcription Factors/metabolism | 3 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 8 | 0.0 |
Enzyme Inhibitors/pharmacology | 18 | 0.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors/*metabolism | 10 | 17.0 |
Receptors, Fc/*metabolism | 4 | 11.0 |
Cell Adhesion | 5 | 0.0 |
Cells, Cultured | 20 | 0.0 |
Endothelium, Vascular/metabolism | 2 | 0.0 |
Enzyme Precursors/*metabolism | 53 | 45.0 |
Microfilament Proteins/*metabolism | 2 | 3.0 |
Protein-Tyrosine Kinase/*metabolism | 62 | 7.0 |
Time Factors | 6 | 0.0 |
von Willebrand Factor/metabolism | 2 | 0.0 |
Basophil Degranulation Test | 2 | 33.0 |
Mast Cells/*immunology | 3 | 11.0 |
Mice, Transgenic | 4 | 0.0 |
Receptors, IgG/*immunology | 2 | 6.0 |
Blotting, Western | 10 | 0.0 |
Cytoskeleton/*metabolism | 2 | 1.0 |
Fibrinogen/metabolism | 3 | 1.0 |
Mice, Knockout | 8 | 0.0 |
Mutation | 7 | 0.0 |
Platelet Glycoprotein GPIIb-IIIa Complex/*metabolism | 3 | 10.0 |
Protein Binding | 26 | 0.0 |
Substrate Specificity | 10 | 0.0 |
src-Family Kinases/antagonists & | 2 | 100.0 |
Down-Regulation/*immunology | 3 | 5.0 |
Enzyme Precursors/antagonists & inhibitors/metabolism | 2 | 40.0 |
Phagocytosis/*immunology | 3 | 5.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors/metabolism | 3 | 4.0 |
Signal Transduction/*immunology | 20 | 5.0 |
Tyrosine/antagonists & inhibitors/metabolism | 2 | 22.0 |
CHO Cells | 5 | 0.0 |
Dimerization | 4 | 0.0 |
Dose-Response Relationship, Drug | 5 | 0.0 |
Hamsters | 6 | 0.0 |
Transfection | 35 | 0.0 |
von Willebrand Factor/pharmacology | 2 | 13.0 |
B-Lymphocytes/*enzymology/metabolism | 2 | 50.0 |
Chickens | 14 | 1.0 |
Enzyme Precursors/chemistry/metabolism | 2 | 50.0 |
Peptide Fragments/chemistry | 2 | 1.0 |
Protein-Tyrosine Kinase/chemistry/*metabolism | 5 | 13.0 |
In Vitro | 11 | 0.0 |
Phospholipase C/metabolism | 12 | 4.0 |
Platelet Glycoprotein GPIb-IX Complex/*metabolism | 2 | 4.0 |
Platelet Membrane Glycoproteins/*metabolism | 5 | 4.0 |
Pyrimidines/*pharmacology | 2 | 3.0 |
Receptors, Fc/metabolism | 3 | 6.0 |
Enzyme Precursors/genetics/*metabolism | 11 | 64.0 |
Kinetics | 22 | 0.0 |
Protein-Tyrosine Kinase/genetics/*metabolism | 13 | 9.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 8 | 0.0 |
Antigens, CD/genetics/*metabolism | 2 | 2.0 |
*Cell Cycle Proteins | 7 | 0.0 |
Cytoplasm/metabolism | 5 | 0.0 |
Enzyme Activation | 51 | 1.0 |
Integrin beta3 | 3 | 6.0 |
Platelet Membrane Glycoproteins/genetics/*metabolism | 2 | 25.0 |
Proto-Oncogene Proteins/metabolism | 10 | 0.0 |
src Homology Domains | 23 | 4.0 |
Antigens, CD/genetics/metabolism | 2 | 3.0 |
Calcium/metabolism | 24 | 1.0 |
Mitogen-Activated Protein Kinase 3 | 2 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 9 | 0.0 |
Phosphotyrosine/*metabolism | 5 | 8.0 |
Protein-Tyrosine-Phosphatase/*metabolism | 4 | 3.0 |
Receptors, Antigen, B-Cell/*metabolism | 9 | 11.0 |
Receptors, IgG/genetics/metabolism | 2 | 33.0 |
Receptors, Immunologic/genetics/*metabolism | 2 | 5.0 |
Tumor Cells, Cultured | 33 | 0.0 |
*src Homology Domains | 9 | 4.0 |
Pyrimidines/pharmacology | 2 | 1.0 |
Receptors, IgG/*physiology | 3 | 10.0 |
Saccharomyces cerevisiae | 3 | 1.0 |
Comparative Study | 9 | 0.0 |
Enzyme Activation/drug effects | 5 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Amino Acid Motifs | 4 | 0.0 |
U937 Cells | 2 | 0.0 |
src-Family Kinases/metabolism | 20 | 10.0 |
Binding Sites | 18 | 0.0 |
Hydrogen Peroxide/pharmacology | 3 | 1.0 |
Sequence Homology, Amino Acid | 10 | 0.0 |
Tyrosine/*metabolism | 16 | 4.0 |
DNA, Complementary/genetics | 3 | 0.0 |
Sequence Alignment | 6 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Models, Molecular | 6 | 0.0 |
Mutagenesis, Insertional | 4 | 1.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Protein Conformation | 3 | 0.0 |
Protein Structure, Tertiary | 10 | 0.0 |
RNA, Messenger/metabolism | 5 | 0.0 |
Sequence Deletion | 2 | 0.0 |
Cell Culture Techniques | 2 | 0.0 |
Protein-Tyrosine Kinase/metabolism/*physiology | 2 | 7.0 |
Carrier Proteins/metabolism | 4 | 0.0 |
Macromolecular Substances | 5 | 0.0 |
Phosphoproteins/metabolism | 14 | 2.0 |
Phosphorylation/drug effects | 10 | 1.0 |
Protein Subunits | 2 | 0.0 |
Protein-Tyrosine-Phosphatase/metabolism | 6 | 4.0 |
Rats | 37 | 0.0 |
Receptors, IgE/chemistry/*metabolism | 4 | 66.0 |
Enzyme Precursors/*genetics | 7 | 6.0 |
Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Protein-Tyrosine Kinase/*genetics | 7 | 3.0 |
Antibody Formation | 2 | 0.0 |
B-Lymphocytes/cytology/*enzymology | 2 | 40.0 |
Cell Cycle | 2 | 0.0 |
Gene Expression Regulation | 4 | 0.0 |
*Lymphocyte Activation | 6 | 0.0 |
Mice, Mutant Strains | 2 | 0.0 |
Protein Processing, Post-Translational | 2 | 0.0 |
src-Family Kinases/physiology | 4 | 12.0 |
Amino Acid Motifs/immunology | 2 | 14.0 |
Enzyme Precursors/*physiology | 6 | 40.0 |
Lymphocyte Activation | 11 | 0.0 |
Protein-Tyrosine Kinase/*physiology | 7 | 5.0 |
src Homology Domains/immunology | 2 | 7.0 |
src-Family Kinases/*physiology | 2 | 5.0 |
Calcium/physiology | 2 | 0.0 |
Enzyme Precursors/antagonists & inhibitors/*metabolism | 8 | 80.0 |
Protein Kinase C/metabolism | 5 | 1.0 |
Receptors, IgE/physiology | 4 | 44.0 |
Virulence Factors, Bordetella/pharmacology | 2 | 1.0 |
Proteins/*metabolism | 4 | 0.0 |
RANTES/*biosynthesis | 2 | 16.0 |
p38 Mitogen-Activated Protein Kinases | 3 | 0.0 |
1-Phosphatidylinositol 3-Kinase/antagonists & inhibitors/*metabolism | 4 | 6.0 |
Androstadienes/pharmacology | 4 | 1.0 |
Calcium Signaling/drug effects | 2 | 4.0 |
Genistein/pharmacology | 2 | 1.0 |
Quinones/pharmacology | 2 | 1.0 |
Recombinant Proteins/metabolism | 7 | 0.0 |
Collagen/*metabolism | 3 | 1.0 |
DNA Primers | 6 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Platelet Glycoprotein GPIIb-IIIa Complex/metabolism | 2 | 5.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Receptors, Collagen | 4 | 5.0 |
Calcium/*metabolism | 2 | 0.0 |
Cell Separation | 2 | 0.0 |
Enzyme Activation/immunology | 4 | 3.0 |
Immunoglobulin E/*physiology | 2 | 28.0 |
Immunophenotyping | 2 | 0.0 |
Intracellular Fluid/enzymology/immunology/metabolism | 2 | 100.0 |
Apoptosis | 4 | 0.0 |
Disease Progression | 3 | 0.0 |
Enzyme Precursors/genetics/*physiology | 2 | 100.0 |
Mice, Inbred C57BL | 7 | 0.0 |
Peptide Fragments/metabolism/pharmacology | 2 | 6.0 |
Signal Transduction/physiology | 11 | 1.0 |
Tumor Necrosis Factor-alpha/*metabolism | 2 | 0.0 |
Catalysis | 5 | 0.0 |
Green Fluorescent Proteins | 3 | 0.0 |
Receptors, Antigen, B-Cell/immunology/*metabolism | 3 | 27.0 |
Proto-Oncogene Proteins/*metabolism | 8 | 0.0 |
Up-Regulation/immunology | 2 | 1.0 |
B-Lymphocytes/*metabolism | 5 | 2.0 |
src-Family Kinases/genetics/*metabolism | 2 | 9.0 |
1-Phosphatidylinositol 3-Kinase/*metabolism | 3 | 1.0 |
Actins/metabolism | 3 | 0.0 |
Retroviridae Proteins, Oncogenic/*metabolism | 3 | 10.0 |
Calcium/*physiology | 2 | 1.0 |
Membrane Glycoproteins/*physiology | 2 | 0.0 |
Enzyme Precursors/physiology | 3 | 21.0 |
Interleukin-2/genetics | 2 | 2.0 |
Mast Cells/*metabolism | 4 | 10.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
*Protein-Serine-Threonine Kinases | 2 | 0.0 |
Protein-Tyrosine Kinase/physiology | 2 | 1.0 |
Proto-Oncogene Proteins/*physiology | 2 | 0.0 |
Tumor Necrosis Factor-alpha/genetics | 2 | 0.0 |
Protein Isoforms | 3 | 0.0 |
Cytoskeleton/metabolism | 3 | 1.0 |
Platelet Aggregation/drug effects | 5 | 2.0 |
Signal Transduction/*drug effects | 3 | 0.0 |
Cell Degranulation/drug effects | 2 | 9.0 |
Cross-Linking Reagents/pharmacology | 2 | 1.0 |
Signal Transduction/drug effects | 3 | 0.0 |
Mast Cells/metabolism | 2 | 7.0 |
Apoptosis/*physiology | 2 | 0.0 |
*Protein Processing, Post-Translational | 2 | 0.0 |
Enzyme Precursors/*immunology | 2 | 22.0 |
Protein-Tyrosine Kinase/*immunology | 2 | 13.0 |
Mitogen-Activated Protein Kinases/*metabolism | 3 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 7 | 1.0 |
Swine | 8 | 0.0 |
src Homology Domains/*genetics | 2 | 6.0 |
Cytoskeleton/enzymology | 2 | 25.0 |
Ion Transport | 2 | 2.0 |
src-Family Kinases/antagonists & inhibitors/*metabolism | 2 | 11.0 |
Lymphoma, B-Cell | 2 | 5.0 |
Mutagenesis | 4 | 0.0 |
Proteins/metabolism | 5 | 0.0 |
T-Lymphocytes/physiology | 2 | 1.0 |
Vanadates/pharmacology | 3 | 2.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Receptors, IgG/physiology | 3 | 8.0 |
Carrier Proteins/genetics/*physiology | 2 | 2.0 |
B-Lymphocytes/immunology | 2 | 0.0 |
Receptors, Immunologic/*metabolism | 2 | 1.0 |
Signal Transduction/genetics | 3 | 1.0 |
Chromatography, Affinity | 2 | 0.0 |
Gene Expression | 4 | 0.0 |
Molecular Weight | 6 | 0.0 |
Spodoptera | 2 | 0.0 |
Conserved Sequence/genetics | 2 | 1.0 |
*Evolution, Molecular | 3 | 0.0 |
Structure-Activity Relationship | 10 | 0.0 |
Cell Membrane/chemistry | 2 | 1.0 |
*Membrane Proteins | 3 | 0.0 |
Receptors, IgE/metabolism | 2 | 6.0 |
Histamine Release | 4 | 6.0 |
Isoenzymes/metabolism | 10 | 1.0 |
Phenylalanine/genetics | 3 | 10.0 |
Retroviridae Proteins, Oncogenic/metabolism | 2 | 5.0 |
Cell Membrane/enzymology/immunology | 2 | 25.0 |
Erythrocytes/immunology | 2 | 0.0 |
Phagocytosis/drug effects/*immunology | 2 | 18.0 |
Sheep | 5 | 0.0 |
DNA, Complementary/chemistry/genetics | 2 | 0.0 |
Hydra/enzymology/*genetics | 2 | 100.0 |
In Situ Hybridization | 3 | 0.0 |
Phylogeny | 2 | 0.0 |
Antibodies, Monoclonal/*immunology | 2 | 0.0 |
Binding, Competitive | 3 | 0.0 |
Tyrosine/chemistry | 3 | 2.0 |
Antigens, CD19/metabolism | 2 | 8.0 |
Phosphatidylinositol Phosphates/metabolism | 2 | 4.0 |
Glutathione Transferase/metabolism | 3 | 0.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Phosphoproteins/isolation & purification/*metabolism | 2 | 6.0 |
Recombinant Fusion Proteins/metabolism | 7 | 0.0 |
src-Family Kinases/*metabolism | 8 | 5.0 |
Antibodies/pharmacology | 2 | 0.0 |
COS Cells | 14 | 0.0 |
Point Mutation | 4 | 0.0 |
Receptors, Antigen, T-Cell/*physiology | 5 | 3.0 |
Antioxidants/pharmacology | 3 | 1.0 |
Cell Size/drug effects | 2 | 2.0 |
Drug Synergism | 2 | 0.0 |
Reactive Oxygen Species/*metabolism | 3 | 1.0 |
Cell Adhesion Molecules/*metabolism | 2 | 0.0 |
Mutagenesis, Site-Directed | 10 | 0.0 |
Phosphoproteins/chemistry/*metabolism | 2 | 3.0 |
Receptors, Antigen, T-Cell/metabolism | 2 | 1.0 |
T-Lymphocytes/immunology/metabolism | 2 | 1.0 |
Hydrogen-Ion Concentration | 3 | 0.0 |
*Mitogen-Activated Protein Kinases | 4 | 1.0 |
Antigens, Differentiation, B-Lymphocyte/*metabolism | 2 | 5.0 |
*Cell Adhesion Molecules | 3 | 1.0 |
Isoenzymes/*metabolism | 3 | 1.0 |
*Lectins | 3 | 1.0 |
Phospholipase C/*metabolism | 4 | 3.0 |
Rabbits | 3 | 0.0 |
Receptors, Antigen, B-Cell/metabolism | 4 | 8.0 |
GTP-Binding Proteins/metabolism | 2 | 0.0 |
Models, Biological | 3 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 3 | 0.0 |
Protein-Tyrosine-Phosphatase/genetics/metabolism | 2 | 11.0 |
Antigens, CD18/*metabolism | 2 | 10.0 |
Cell Fractionation | 2 | 0.0 |
Phosphopeptides/*metabolism | 2 | 20.0 |
Protein Kinase C/*metabolism | 2 | 0.0 |
Enzyme Precursors/chemistry/*metabolism | 2 | 50.0 |
Gene Expression Regulation, Enzymologic | 4 | 0.0 |
Receptor Aggregation | 6 | 6.0 |
Chromatography, High Pressure Liquid | 2 | 0.0 |
Protein-Tyrosine Kinase/*blood | 2 | 25.0 |
*Drug Design | 2 | 2.0 |
Protein-Tyrosine Kinase/*antagonists & inhibitors/metabolism | 2 | 4.0 |
Alternative Splicing | 2 | 0.0 |
Cell Membrane/metabolism | 5 | 0.0 |
Models, Genetic | 3 | 0.0 |
Tretinoin/pharmacology | 2 | 0.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 4 | 1.0 |
Chimeric Proteins/biosynthesis | 3 | 6.0 |
GTP-Binding Proteins/*metabolism | 2 | 0.0 |
*Phosphoproteins | 2 | 1.0 |
Receptors, Antigen, B-Cell/metabolism/physiology | 2 | 28.0 |
rac GTP-Binding Proteins | 2 | 1.0 |
ras Proteins/metabolism | 2 | 1.0 |
Adenosine Diphosphate/pharmacology | 2 | 1.0 |
Biological Transport | 3 | 0.0 |
Membrane Proteins/*metabolism | 2 | 0.0 |
Thrombin/pharmacology | 5 | 2.0 |
Cell Adhesion Molecules/metabolism | 4 | 1.0 |
Cytoskeletal Proteins/metabolism | 2 | 0.0 |
Tubulin/*metabolism | 2 | 6.0 |
Cross-Linking Reagents | 5 | 1.0 |
Phosphopeptides/metabolism | 3 | 10.0 |
*Ubiquitin-Protein Ligases | 4 | 0.0 |
Antigens, CD/metabolism | 2 | 0.0 |
Receptors, Antigen, B-Cell/*physiology | 2 | 2.0 |
Enzyme Precursors/*chemistry/*metabolism | 2 | 100.0 |
Glutathione Transferase | 2 | 4.0 |
Protein-Tyrosine Kinase/*chemistry/*metabolism | 2 | 13.0 |
Chromones/pharmacology | 2 | 0.0 |
Mice, Inbred BALB C | 5 | 0.0 |
Morpholines/pharmacology | 2 | 0.0 |
Antibodies, Antineutrophil Cytoplasmic/*immunology | 2 | 7.0 |
Immunoglobulin M/*immunology | 2 | 3.0 |
Phagocytosis | 3 | 0.0 |
Cell Line, Tumor | 6 | 0.0 |
Mitogen-Activated Protein Kinase 1 | 2 | 1.0 |
*Chromosome Mapping | 2 | 0.0 |
Receptors, IgE/*metabolism | 9 | 25.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism | 2 | 0.0 |
Receptors, Antigen, T-Cell/physiology | 2 | 1.0 |
*Adaptor Proteins, Vesicular Transport | 2 | 0.0 |
Crystallography, X-Ray | 2 | 0.0 |
Receptors, IgE/*physiology | 5 | 35.0 |
T-Lymphocytes/*immunology | 3 | 0.0 |
Neutrophils/*metabolism | 3 | 1.0 |
Osmotic Pressure | 2 | 3.0 |
Antigens, CD/*physiology | 2 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 3 | 0.0 |
Signal Transduction/genetics/*immunology | 4 | 4.0 |
Inositol 1,4,5-Trisphosphate/metabolism | 2 | 3.0 |
Lymphoma | 2 | 5.0 |
Phosphatidylinositols/metabolism | 3 | 2.0 |
Cell Membrane/immunology/physiology | 2 | 22.0 |
Glutathione Transferase/biosynthesis | 2 | 6.0 |
Recombinant Fusion Proteins/biosynthesis | 2 | 0.0 |
Phagocytosis/*physiology | 2 | 4.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Hematopoietic Stem Cells/metabolism | 2 | 1.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
Monocytes/*metabolism | 3 | 0.0 |
Enzyme Precursors/immunology/*metabolism | 3 | 75.0 |
Protein-Tyrosine Kinase/immunology/*metabolism | 4 | 21.0 |
Antibody Specificity | 2 | 0.0 |
Leukemia, Basophilic, Acute | 5 | 41.0 |
*Receptor Aggregation | 2 | 15.0 |
Blood Platelets/*enzymology | 3 | 4.0 |
Platelet Activation/physiology | 2 | 7.0 |
Antigens/immunology | 3 | 2.0 |
Enzyme Precursors/genetics/*immunology/metabolism | 2 | 100.0 |
Protein-Tyrosine Kinase/genetics/*immunology/metabolism | 2 | 100.0 |
T-Lymphocytes/immunology | 2 | 0.0 |
HL-60 Cells | 3 | 0.0 |
B-Lymphocytes/*immunology/metabolism | 2 | 4.0 |
Recombinant Fusion Proteins | 3 | 0.0 |
Enzyme Precursors/genetics/physiology | 2 | 66.0 |
Immunization | 2 | 0.0 |
Protein-Tyrosine Kinase/genetics/physiology | 3 | 20.0 |
Receptors, Antigen, B-Cell/*immunology | 2 | 5.0 |
Arachidonic Acid/metabolism | 2 | 2.0 |
Platelet Activation/*drug effects | 2 | 3.0 |
Platelet Aggregation | 2 | 1.0 |
Serotonin/metabolism | 3 | 3.0 |
Spleen/enzymology | 2 | 6.0 |
Cell Degranulation | 3 | 7.0 |
Genetic Vectors | 4 | 0.0 |
Vaccinia virus | 2 | 9.0 |
*Phosphotyrosine | 2 | 33.0 |
Peptide Mapping | 3 | 0.0 |
Phosphotyrosine | 9 | 3.0 |
Receptors, Antigen, B-Cell/isolation & purification/*metabolism | 2 | 50.0 |
Signal Transduction/immunology | 3 | 0.0 |
3T3 Cells | 2 | 0.0 |
Vaccinia virus/genetics | 2 | 2.0 |
Bone Marrow Cells | 2 | 0.0 |
Enzyme Activation/genetics/immunology | 2 | 10.0 |
Receptors, IgE/genetics/*immunology/metabolism | 2 | 100.0 |
Isoenzymes/antagonists & inhibitors/*metabolism | 2 | 5.0 |
Phospholipase C/antagonists & inhibitors/*metabolism | 2 | 33.0 |
Enzyme Precursors/*chemistry | 2 | 33.0 |
Protein-Tyrosine Kinase/*chemistry | 2 | 10.0 |
Blood Platelets/*drug effects/enzymology | 3 | 37.0 |
*Platelet Aggregation/drug effects | 2 | 6.0 |
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 4 | 1.0 |
Antibodies/metabolism | 2 | 2.0 |
Integrins/*metabolism | 2 | 1.0 |
Recombinant Proteins | 3 | 0.0 |
Blood Platelets/*drug effects | 2 | 5.0 |
Antigens | 2 | 2.0 |
Peptide Fragments/chemistry/isolation & purification | 2 | 5.0 |
Phosphopeptides/chemistry/isolation & purification | 2 | 10.0 |
Receptors, Antigen, B-Cell/genetics/*metabolism | 2 | 40.0 |
DNA Primers/genetics | 2 | 0.0 |
Protein-Tyrosine Kinase/isolation & purification/*metabolism | 2 | 10.0 |
Cercopithecus aethiops | 4 | 0.0 |
Enzyme Precursors/biosynthesis/*metabolism | 2 | 40.0 |
*Phagocytosis | 2 | 1.0 |
Protein-Tyrosine Kinase/biosynthesis/*metabolism | 2 | 18.0 |
Clone Cells | 2 | 0.0 |
Peptides/chemistry | 3 | 0.0 |
Consensus Sequence | 2 | 0.0 |
Tyrosine/analogs & derivatives/analysis | 2 | 5.0 |
Tyrosine/analogs & derivatives/metabolism | 4 | 3.0 |
Enzyme Precursors/*antagonists & inhibitors | 3 | 50.0 |
*src-Family Kinases | 2 | 4.0 |
*Genes, Tumor Suppressor | 2 | 0.0 |
Enzyme Precursors/biosynthesis/genetics/metabolism/*physiology | 2 | 100.0 |
Protein-Tyrosine Kinase/biosynthesis/genetics/metabolism/*physiology | 2 | 50.0 |
Macrophages/immunology/metabolism | 2 | 4.0 |
Antigens, CD/physiology | 2 | 0.0 |
Inhibitory Concentration 50 | 2 | 0.0 |
Protein-Tyrosine Kinase/*antagonists & inhibitors | 3 | 1.0 |
Solubility | 2 | 0.0 |
Collagen/pharmacology | 2 | 1.0 |
Protein-Tyrosine Kinase/analysis/*physiology | 2 | 66.0 |
Dose-Response Relationship, Immunologic | 2 | 0.0 |
B-Lymphocytes/pathology | 2 | 2.0 |
Breast Neoplasms/*genetics | 2 | 0.0 |
Oligopeptides/pharmacology | 2 | 1.0 |
